A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers
CompletedNCT02678988
Hoffmann-La RocheHealthy Volunteer
Start: 2016-02-29End: 2016-06-30Updated: 2016-11-02